Beijing, China, June 1 2023 – Recently, Shenzhen Aibo (Abrobo) raised RMB 100 million ($14 million) in a series A round led by Guozhong Venture Capital, followed by Changan Private Capital, with over-subscribed investment from existing shareholder Lenovo Capital and continuous follow-up investment from Changling Capital. Abrobo Medical Robotics will use the funds raised in this round of financing to accelerate the clinical enrollment of the next-generation comprehensive vascular intervention robot, promote the construction of an intelligent vascular intervention robot technology platform, and strengthen the overall capacity building of its team. These measures will help accelerate the research and development and application of the technology, providing doctors with more advanced surgical tools and offering patients safer and more effective treatment options.
Comments